Most Drug Firms Fail To Comply With Key EU HTA Step, EMA Warns

 
• By Eliza Slawther
  
Michael Berntgen's presentation at the annual TOPRA symposium 2025 (Shutterstock)

More from TOPRA

More from Conferences